Dr. Beckwith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14500 99th Ave N
Ste 100
Maple Grove, MN 55369Phone+1 763-898-1000Fax+1 612-625-6919
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of MinnesotaResidency, Internal Medicine, 2006 - 2009
- Medical College of WisconsinClass of 2006
Certifications & Licensure
- MN State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread Start of enrollment: 2018 Nov 28
- A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer Start of enrollment: 2021 Mar 08
Roles: Principal Investigator
Publications & Presentations
PubMed
- Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time.Adnan Shaaban, Ashley Petersen, Heather Beckwith, Natalia Florea, David A Potter
Cardio-Oncology. 2024-05-01 - Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.Haiyun Wang, Douglas Yee, David Potter, Patricia Jewett, Christina Yau
Breast Cancer Research and Treatment. 2024-04-01 - 2 citationsOutcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast c...Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, A Jo Chien, Judy C Boughey
Breast Cancer Research and Treatment. 2023-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: